Chunling Liu Selected Research

aflutinib

11/2022	Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study.
1/2021	Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunling Liu Research Topics

Disease

9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 12/2017
8	Neoplasms (Cancer) 06/2021 - 05/2017
5	Lung Neoplasms (Lung Cancer) 10/2019 - 02/2015
4	Multiple Sclerosis 01/2018 - 09/2011
3	Stroke (Strokes) 05/2010 - 08/2009
2	Neoplasm Metastasis (Metastasis) 11/2022 - 06/2021
2	Disease Progression 11/2022 - 10/2022
2	Diarrhea 10/2022 - 01/2022
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2019
2	Adenocarcinoma of Lung 12/2020 - 02/2015
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 05/2017
2	Carcinogenesis 12/2017 - 10/2015
2	Brain Edema (Cerebral Edema) 11/2015 - 08/2009
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2011 - 05/2010
2	Brain Ischemia (Cerebral Ischemia) 05/2010 - 08/2009
1	Edema (Dropsy) 12/2022
1	Exanthema (Rash) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 06/2021
1	Hypoxia (Hypoxemia) 03/2021
1	Body Weight (Weight, Body) 01/2021
1	Headache (Headaches) 01/2021
1	Pulmonary Hypertension 01/2021
1	Infections 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Pericardial Effusion 01/2021
1	Restless Legs Syndrome (Restless Legs) 01/2021
1	Vitamin D Deficiency 01/2021
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2021
1	Vomiting 11/2020
1	Vertigo (Positional Vertigo) 11/2020
1	Nausea 11/2020
1	Cockayne Syndrome (Syndrome, Cockayne) 10/2019
1	Multiple Myeloma 09/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2019
1	Herpetic Keratitis 07/2019
1	Keratitis 07/2019
1	Chemical Burns (Chemical Burn) 12/2017
1	Inflammation (Inflammations) 05/2017
1	Neuroinflammatory Diseases 05/2017
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2017
1	Hypertension (High Blood Pressure) 01/2017

Drug/Important Bio-Agent (IBA)

5	Progesterone FDA LinkGeneric 09/2011 - 08/2009
4	salicylhydroxamic acid (SHAM)IBA 05/2017 - 05/2010
3	Tyrosine Kinase InhibitorsIBA 11/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 11/2015
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 02/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 09/2019
3	Neuroprotective AgentsIBA 11/2015 - 09/2009
2	aflutinibIBA 11/2022 - 01/2021
2	Gefitinib (Iressa)FDA Link 11/2022 - 01/2022
2	CreatinineIBA 10/2022 - 01/2019
2	Biological ProductsIBA 01/2021 - 12/2017
2	PlatinumIBA 01/2021 - 10/2019
2	Long Noncoding RNAIBA 12/2020 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 09/2019
2	MicroRNAs (MicroRNA)IBA 12/2017 - 10/2015
1	BESIBA 12/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2022
1	SH-1028IBA 10/2022
1	TabletsIBA 10/2022
1	aumolertinibIBA 01/2022
1	ZincIBA 06/2021
1	zinc-binding protein (zinc binding protein)IBA 06/2021
1	PerforinIBA 03/2021
1	Granzymes (Granzyme)IBA 03/2021
1	osimertinibIBA 01/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	niraparibIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Small Nucleolar RNA (snoRNA)IBA 12/2020
1	Ondansetron (Zofran)FDA LinkGeneric 11/2020
1	OxidesIBA 11/2020
1	HydrogelsIBA 11/2020
1	IgA receptor (protein B)IBA 10/2019
1	ONX 0912IBA 09/2019
1	Proteasome InhibitorsIBA 09/2019
1	Acyclovir (Aciclovir)FDA LinkGeneric 07/2019
1	lobaplatinIBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	endostar proteinIBA 01/2018
1	Transforming Growth Factor-beta Type I ReceptorIBA 12/2017
1	Peptides (Polypeptides)IBA 05/2017
1	CarrageenanIBA 05/2017
1	LipopolysaccharidesIBA 05/2017
1	ElementsIBA 05/2017
1	Purinergic P2X7 ReceptorsIBA 05/2017
1	N- (2- chloro- 3- (trifluoromethyl)benzyl)- N- methyl- 5- oxopyrrolidine- 2- carboxamideIBA 05/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	LDL CholesterolIBA 01/2017
1	oxidized low density lipoproteinIBA 01/2017

Therapy/Procedure

4	Therapeutics 11/2022 - 11/2015
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	Immunotherapy 03/2021
1	Phacoemulsification 07/2019
1	Precision Medicine 01/2019
1	Bathroom Equipment 12/2017